Across TCGA pan-cancer cohorts, LINC02610 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated LINC02610 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher LINC02610 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02610 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

THYM, LUAD, and UCEC are the cancer types where LINC02610 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Median	III,IV	0.103	0.944	<.001	42	view →
LUAD	OS	Median	All	0.068	0.812	<.001	36	view →
UCEC	OS	Median	All	1.000	0.660	.027	8	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: LINC02610 tumor-vs-normal RNA expression · all LINC02610 data types